Software: Release 8. College Station, TX: StataCorp LP). The odds ratios and standard errors of Taq1A and À141C I/D for TD were calculated from the individual studies using the 'metan' command, with the pooled odds ratio and standard error calculated under the random effects model. The possible effects of ethnicity, age, and gender ratio on heterogeneity among the studies were assessed by meta-regression analysis using the 'metareg' command. We tested for publication bias using the 'metabias' command.
A recent meta-analysis of association findings for DAOA suggests that multiple risk polymorphisms within the gene are contributing to schizophrenia susceptibility. 1 Specifically, this meta-analysis identified association with single nucleotide polymorphisms (SNPs) downstream of the 3 0 end of the gene (rs3918342 (M23) and rs1421292 (M24)) and with SNPs at the 5 0 end of the gene (rs3916965 (M12) in the putative promoter region and rs2391191 (M15) in exon 2). In addition to being one of the most strongly associated markers in the meta-analysis, M15 is also a putative functional polymorphism causing an arginine-to-lysine substitution at codon 30 (ARG30LYS). The functional impact of this substitution has yet to be determined. Following a recent association between cognitive deficits and M24 at DAOA, 2 we investigated whether the ARG30LYS substitution was also associated with cognitive impairments. We reasoned that such evidence would provide important support for the role of this putative functional polymorphism in brain activity.
After receiving ethical approval, we collected neuropsychological assessments on a subset of 93 consenting patients with DSM-IV schizophrenia from our total case control sample (comprised of 373 cases and 812 controls, all of Irish nationality). All patients were clinically stable, aged between 18 and 60 years, and were free from confounding factors such as epilepsy, substance abuse or acquired brain injury. This subgroup had a mean age of 46.2 years (s.d. = 9.3), was comprised primarily of males (75%) and had a predominantly chronic illness history (duration in years 22.3710.4; range 4-42). ) and the Intra-Extra Dimensional Set Shifting Task from CANTAB (IED). The N-back task was used to index working memory. 6 To include pre-morbid IQ as a co-variable, we administered the Wechsler test of Adult Reading (WTAR 7 ). Symptom severity was also assessed based on worst-ever illness episode using the PANSS.
ARG30LYS was genotyped using the Taqman assay (Applied Biosystems, Warrington, UK) on an ABI PRISM 7900HT Sequence Detection System. We previously reported significant association (corrected for multiple testing) at DAOA with ARG30LYS (P = 0.003, OR = 1.33). 8 In our full sample, it is the ARG allele that is associated with schizophrenia, in keeping with the original association finding. 9 The ARG allele was significantly associated with poorer episodic memory performance as measured by the logical memory subtest, for both the immediate recall and the delayed recall conditions (immediate recall: F 3,84 = 3.74; P = 0.028; delayed recall: F 3,84 = 4.44; P = 0.015; see Supplementary Table 1) . When expressed in terms of task norms, individuals with the LYS/LYS genotype performed only 1 scale point below mean norms, whereas those with ARG/ARG genotype performed 4 scaled score points (over 1 s.d.) below mean norms (see Figure 1) . These significant differences were observed in the absence of differences in age, gender, years of education, symptom severity, prescribed medication or pre-morbid IQ. In a regression analysis, DAOA ARG30LYS genotype explained 6.4% of variance in verbal memory performance after co-varying for the effects of pre-morbid IQ on memory (F change 1,73 = 6.27; P = 0.014). No differences in attentional control, working memory or spatial memory were observed.
In summary, we found that the ARG allele of the DAOA ARG30LYS polymorphism (rs2391191/M15), which is strongly associated with schizophrenia in both a recent meta-analysis and in our own sample, was associated with poorer verbal memory performance among patients. These data are consistent with an earlier report of DAOA's association with both verbal memory performance and hippocampal activation. 2 Furthermore, it represents a rare instance in genetic studies of schizophrenia where the associated SNP is a missense and possibly functional polymorphism. The DAOA gene remains novel with no recognizable functional motifs. The only clue to its role in schizophrenia pathophysiology has come from the original study of DAOA, where DAOA interacted in vitro with D-amino acid oxidase (DAO), suggesting a role for both the genes in NMDA receptor function. 9 The association of ARG30LYS with variance in memory function is consistent with DAOA's hypothesized role in NMDA function, given NMDA's putative involvement in long-term potentiation. Although an arginine-tolysine substitution represents a conservative aminoacid change, a number of examples exist where such a subtle biochemical change to amino-acid sequence resulted in significant alteration of protein function. 10 The actual impact of this missense mutation on DAOA structure or function will become known only when the native protein is isolated and fully characterized.
Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature. com/mp) Figure 1 Mean scaled score differences in verbal memory recall on the WMS logical memory subtest according to DAOA ARG30LYS genotype.
